Comparative toxicity of dithiocarbamates and butadiene metabolites in human lymphoid and bone marrow cells.
Apparent differences in the pattern of leukemia risk have been observed between workers employed in 1,3-butadiene (BD) monomer production and those working in styrene-butadiene rubber production (SBR). There are a number of possible explanations for these discrepancies, including differences in disease classification and diagnosis as well as possible quantitative and qualitative differences in occupational exposure between these two industries. This led us to evaluate the possibility that the pattern of disease observed in SBR might be influenced by the presence of an important class of biologically reactive chemicals, dithiocarbamates (DTC), that were present in SBR but not BD monomer production. Therefore, we compared the immunotoxic and hematotoxic activities of DTC and BD metabolites in human immune and hematopoietic cells. Relative to the mouse, human CD34+ bone marrow cells are relatively resistant to the direct effects of BD metabolites, with only the bis-oxide producing any evidence of suppression of clonogenic response at concentrations between 1 and 10 microM. Similarly, treatment of human CD4+ lymphocytes with known (2,3-epoxybutene) and putative BD metabolites (D,L-butane-bis-oxide, (2S,3R)-3-epoxybutane-1,2-diol) does not result in appreciable T-cell toxicity at concentrations likely to be encountered in vivo. In contrast, treatment of human cells with DTC at concentrations as low as 100 nM results in significant suppression of hematopoietic clonogenic response and T-lymphocyte function. Additional studies in our laboratory and others suggest a role for copper in DTC toxicity in both human lymphocytes and bone marrow cells, although the pattern of altered transcriptional regulation observed is markedly different in these two cell populations. These results are consistent with the pattern of DTC toxicity previously observed in clinical and molecular studies.
Irons
R D
RD
University of Colorado Health Sciences Center, 4200 East 9th Avenue, C238, Denver, CO 80262, USA. richard.irons@uchsc.edu
Stillman
W S
WS
Pyatt
D W
DW
Yang
Y
Y
Le
A
A
Gustafson
D L
DL
Hua Zheng
J
J
D000818:Animals; D001854:Bone Marrow Cells / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D002070:Butadienes / Q000138:chemical synthesis / Q000378:metabolism* / Q000633:toxicity*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D002617:Chemical Industry; D003114:Colony-Forming Units Assay; D020724:Elastomers; D006801:Humans; D066298:In Vitro Techniques; D007938:Leukemia / Q000139:chemically induced; D051379:Mice; D009784:Occupational Diseases / Q000139:chemically induced; D018570:Risk Assessment; D013343:Styrenes / Q000138:chemical synthesis; D013859:Thiocarbamates / Q000633:toxicity*
D002070:Butadienes; D020724:Elastomers; D013343:Styrenes; D013859:Thiocarbamates; C065815:styrene-butadiene rubber; C031763:1,3-butadiene